A Deep Dive Into CGM Data

This activity was originally presented during the 2025 PTCE Diabetes Day of Education on May 29, 2025.

This activity includes patient counseling video vignettes.

Program Description
This session will focus on understanding and interpreting continuous glucose monitoring (CGM) metrics. Faculty will integrate CGM data analysis with the ADA Standards of Care, demonstrating how these data, in conjunction with guideline recommendations, can optimize the care plan for individuals living with diabetes. Patient counseling strategies covering the interpretation of trend arrows, personalized alert settings, and appropriate responses to high and low glucose alerts will also be covered. Included patient counseling videos will illustrate best practices when reviewing CGM data and making real-time decisions based on CGM data.

Target Audience: Community pharmacists and pharmacy technicians

Type of Activity: Application
Release date: June 4, 2025
Expiration date: June 4, 2026
Learner level: Foundational
Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Examine people living with diabetes for whom use of a continuous glucose monitoring (CGM) device would be appropriate based on preferences and glycemic goals 
• Analyze CGM data and key metrics to identify trends and effectiveness of current treatment regimens
• Determine how to use CGM data to make informed decisions about diabetes management and appropriate adjustments

Pharmacy Times Continuing Education^™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hours (0.10 CEU) under the ACPE universal activity numbers 0290-0000-25-175-H01-P and 0290-0000-25-175-H01-T. The activity is available for CE credit through June 4, 2026.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, view the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

Amy Hess-Fischl, MS, RDN, LDN, BC-ADM, CDCES, has the following relevant financial relationships with commercial interests to disclose:

Consultant: ADCES
Speakers Bureau: Abbott Diabetes Care, Insulet, Sanofi, Xeris

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Susan Cornell, PharmD, CDCES, FAPhA, FADCES

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Dipti Desai, PharmD, MBA, CHCP; Liza Patel, PharmD, RPh; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta.

At least one anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms